Claims
- 1. A compound of the formula ##STR19## or a physiologically tolerable acid addition salt thereof, wherein R.sup.1 and R.sup.1' are the same or different and are hydrogen, allyl, halogen, nitro, or alkyl or alkoxy having 1 to 4 carbon atoms; R.sup.2 has the formula ##STR20## wherein R.sup.5 is hydrogen, alkyl having 1 to 5 carbon atoms, aryl, aryl-lower alkyl, or aryl or aryl-lower alkyl substituted by lower alkyl or alkoxy, R.sup.6 is hydrogen or alkyl having 1 to 8 carbon atoms, and R.sup.7 is hydrogen, lower alkyl, or aryl-lower alkyl; R.sup.3, taken alone, is hydrogen; R.sup.4, taken alone, is ##STR21## wherein Alk is alkyl having 1 to 3 carbon atoms, n is a number from 1 to 3, R.sup.8 and R.sup.9, taken alone, are the same or different and are hydrogen, alkoxy having 1 to 3 carbon atoms, or benzyloxy, or R.sup.8 and R.sup.9, taken together, are bis-methylene-dioxy; or R.sup.3 and R.sup.4, taken together with the nitrogen atom to which they are attached, are a heterocyclic ring having 5 to 7 members, or such a ring substituted by alkyl having 1 to 4 carbon atoms, or such a ring, unsubstituted or substituted by alkyl having 1 to 4 carbon atoms, wherein one carbon atom may be replaced by oxygen, sulfur, or nitrogen, which latter may be unsubstituted or substituted by alkyl, alkoxy, oxalkyl, acyl, or carbalkoxy each having 1 to 5 carbon atoms, by pyridyl, by phenyl, or by phenyl mono-substituted or poly-substituted by hydroxy, halogen, or alkyl or alkoxy having 1 to 4 carbon atoms.
- 2. A compound or salt as in claim 1 wherein, if R.sup.3, taken alone, is hydrogen, then R.sup.4, taken alone, is ##STR22##
- 3. A pharmaceutical composition comprising a therapeutically-effective amount of a compound as in claim 1 together with a pharmaceutically suitable carrier therefor.
- 4. A pharmaceutical composition comprising a therapeutically-effective amount of a compound as in claim 2 together with a pharmaceutically-suitable carrier therefor.
- 5. A method for treating coronary disease in a patient suffering therefrom which comprises administering to said patient a therapeutically-effective amount of a compound as in claim 1.
- 6. A method for treating coronary disease in a patient suffering therefrom which comprises administering to said patient a therapeutically-effective amount of a compound as in claim 2.
Priority Claims (1)
Number |
Date |
Country |
Kind |
26233147 |
May 1977 |
DEX |
|
Parent Case Info
This is a continuation-in-part of application Ser. No. 799,676 filed May 23, 1977 now abandoned.
US Referenced Citations (4)
Number |
Name |
Date |
Kind |
3644469 |
Koppe et al. |
Feb 1972 |
|
3663607 |
Barrett et al. |
May 1972 |
|
3857873 |
Schwender et al. |
Dec 1974 |
|
4014920 |
Jaeggi et al. |
Mar 1977 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
799676 |
May 1977 |
|